Conference Coverage

COVID-19 vaccine supply will be limited at first, ACIP says


 

‘Ultra-cold’ temperatures required for storage

Both vaccines require storage at lower temperatures than is usually needed for vaccines. One vaccine must be distributed and stored at -20° C, and the other must be stored, distributed, and handled at -70° C.

This issue stands out most to ACIP Chair Jose Romero, MD. He says the “ultra-cold” temperatures required for storage and transportation of the vaccines will be a “significant problem” for those in rural areas.

High-risk populations such as meat processors and agricultural workers “may have to wait until we have a more stable vaccine that can be transported and delivered more or less at room temperature,” Romero explained. He is the chief medical officer at the Arkansas Department of Health and is a professor of pediatrics and pediatric infectious diseases at the University of Arkansas for Medical Sciences, both in Little Rock.

The advisory committee will meet again on September 22. At that time, they’ll vote on an interim plan for prioritization of the first COVID-19 vaccine.

This article first appeared on Medscape.com.

Pages

Recommended Reading

‘The pandemic within the pandemic’
MDedge Rheumatology
FDA authorizes convalescent plasma for COVID-19
MDedge Rheumatology
Research examines links between ‘long COVID’ and ME/CFS
MDedge Rheumatology
Study confirms it’s possible to catch COVID-19 twice
MDedge Rheumatology
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
MDedge Rheumatology
First evidence of SARS-CoV-2 in heart cells
MDedge Rheumatology
When viruses collide: Flu season during pandemic
MDedge Rheumatology
Prognosis for rural hospitals worsens with pandemic
MDedge Rheumatology
Convalescent plasma actions spark trial recruitment concerns
MDedge Rheumatology
Asymptomatic SARS-CoV-2 infections in kids tied to local rates
MDedge Rheumatology